Jens Ackerstaff

USPTO Granted Patents = 25 (Patent Applications = 15)

EPO Patents = 11 (Patent Applications = 30)

Average Co-Inventor Count = 11.0

ph-index = 11

Forward Citations = 256(Granted Patents)

Location History:

Berlin, DE (2014 - 2016)
Düsseldorf, DE (2013 - 2020)
Duesseldorf, DE (2021)
Dusseldorf, DE (2022 - 2024)

Company Filing History:

13 out of 378

Bayer Pharma Aktiengesellschaft

patents

8 out of 721

Bayer Intellectual Property Gmbh

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

25 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12064429 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2024-08-20),

2. 11439642 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2022-09-13),

3. 11180471 - Substituted oxopyridine derivatives (2021-11-23),

4. 10736896 - Substituted 5-fluoro-1H-pyrazolopyridines and their use (2020-08-11),

5. 10421742 - Substituted oxopyridine derivatives (2019-09-24),

6. 10300062 - Bicyclically substituted uracils and the use thereof (2019-05-28),

7. 10167280 - Substituted oxopyridine derivatives (2019-01-01),

8. 9993476 - Substituted 5-flouro-1H-pyrazolopyridines and their use (2018-06-12),

9. 9949978 - Bicyclically substituted uracils and the use thereof (2018-04-24),

10. 9949977 - Bicyclically substituted uracils and the use thereof (2018-04-24),

11. 9926305 - Salts (2018-03-27),

12. 9884063 - Amido-substituted azole compounds (2018-02-06),

13. 9751843 - Substituted uracils and use thereof (2017-09-05),

14. 9695131 - Substituted uracils as chymase inhibitors (2017-07-04),

15. 9682995 - Amino-substituted isothiazoles (2017-06-20),

Title: Jens Ackerstaff: Innovating the Future in Düsseldorf

Introduction:

Jens Ackerstaff, a prolific inventor based in the vibrant city of Düsseldorf, Germany, has been at the forefront of innovation in various industries. With a remarkable dedication to pushing the boundaries of technology, Jens has secured 24 patents over the course of his impressive career.

Latest Patents:

Jens Ackerstaff's latest patents include groundbreaking innovations in the field of medicine and pharmaceuticals. One of his patents focuses on substituted 5-fluoro-1H-pyrazolopyridines, showcasing his commitment to developing novel compounds for the treatment and prophylaxis of cardiovascular disorders. Additionally, his work on substituted oxopyridine derivatives highlights his contribution to the field of ophthalmic disorders and cardiovascular health.

Career Highlights:

Throughout his career, Jens Ackerstaff has made significant strides in the pharmaceutical industry. He has worked with renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH, where his passion for innovation has led to the development of pioneering medical solutions.

Collaborations:

Jens Ackerstaff's collaborative spirit has been instrumental in his success as an inventor. Working alongside esteemed colleagues like Volkhart Min-Jian Li and Markus Follmann, Jens has been able to exchange ideas, drive innovation, and bring groundbreaking inventions to life.

Conclusion:

In conclusion, Jens Ackerstaff's dedication to innovation and his exceptional contributions to various industries have solidified his position as a standout inventor in Düsseldorf, Germany. His relentless pursuit of excellence and forward-thinking approach continue to inspire those around him, shaping the future of technology and medicine.

This text is generated by artificial intelligence and may not be accurate.